{"id":"https://openalex.org/W3203322872","doi":"https://doi.org/10.1136/jitc-2021-itoc8.41","title":"P06.07 In vivostudies of immunomodulatory a-CTLA-4 antibody in a humanized mouse model","display_name":"P06.07 In vivostudies of immunomodulatory a-CTLA-4 antibody in a humanized mouse model","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3203322872","doi":"https://doi.org/10.1136/jitc-2021-itoc8.41","mag":"3203322872"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-itoc8.41","doi":"https://doi.org/10.1136/jitc-2021-itoc8.41","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-itoc8.41","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_1/A22.1.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Poster Presentations","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_1/A22.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005395885","display_name":"Carmen Reitinger","orcid":"https://orcid.org/0000-0003-0515-5119","observed_orcids":["https://orcid.org/0000-0003-0515-5119"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C Reitinger","raw_affiliation_strings":["University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086501578","display_name":"Falk Nimmerjahn","orcid":"https://orcid.org/0000-0002-5418-316X","observed_orcids":["https://orcid.org/0000-0002-5418-316X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"F Nimmerjahn","raw_affiliation_strings":["University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I181369854"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27879104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A22.1","last_page":"A22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7620000243186951},{"id":"https://openalex.org/keywords/anti-ctla-4-antibody","display_name":"anti-CTLA-4 antibody","score":0.8920000195503235},{"id":"https://openalex.org/keywords/immunomodulatory-antibodies","display_name":"immunomodulatory antibodies","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/checkpoint-blockade","display_name":"checkpoint blockade","score":0.44999998807907104},{"id":"https://openalex.org/keywords/agonistic-antibodies","display_name":"agonistic antibodies","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cytokine-and-chemokine-production","display_name":"cytokine and chemokine production","score":0.8930000066757202},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.7108441591262817},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6722487211227417},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6521516442298889},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6366110444068909},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6075526475906372},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5982102155685425},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5295611023902893},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5033096671104431},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4898059070110321},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4800218641757965},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4793722927570343},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4507359564304352},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.44816139340400696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42769408226013184},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4194828271865845},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.4113059937953949},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4108871817588806},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30926936864852905},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07467573881149292},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2021-itoc8.41","doi":"https://doi.org/10.1136/jitc-2021-itoc8.41","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-itoc8.41","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_1/A22.1.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Poster Presentations","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-itoc8.41","doi":"https://doi.org/10.1136/jitc-2021-itoc8.41","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-itoc8.41","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_1/A22.1.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Poster Presentations","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203322872.pdf","grobid_xml":"https://content.openalex.org/works/W3203322872.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W2044835625","https://openalex.org/W2121556079"],"related_works":["https://openalex.org/W2905296663","https://openalex.org/W2962340919","https://openalex.org/W4249831286","https://openalex.org/W2955912560","https://openalex.org/W3090734545","https://openalex.org/W2990545804","https://openalex.org/W2809733766","https://openalex.org/W2169794517","https://openalex.org/W2797031998","https://openalex.org/W1604528048"],"abstract_inverted_index":{"Background":[0],"Recent":[1],"findings":[2],"in":[3,44,51,61,94,112,120,138,156,169,179,204,260,275],"cancer":[4,75,92],"immunotherapy":[5,93,241],"have":[6],"reinforced":[7],"the":[8,11,27,59,89,95,105,121,132,139,153,163,188,252,257],"hypothesis":[9],"that":[10,68,144],"immune":[12,24,100,126,258],"system":[13,259],"is":[14,79],"able":[15],"to":[16,29,66,81,134,152,186],"control":[17,199],"most":[18],"cancers.":[19],"Immunomodulatory":[20],"antibodies":[21,116,137,168,193,200],"can":[22,117,219],"enhance":[23],"responses,":[25],"having":[26],"potential":[28],"generate":[30],"anti-cancer":[31],"immunity.1\u20134":[32],"Materials":[33],"and":[34,197,254],"Methods":[35],"Most":[36],"current":[37],"studies":[38],"addressing":[39],"this":[40],"question":[41],"are":[42,172],"performed":[43],"murine":[45],"mouse":[46,85,110,141],"model":[47,178],"systems":[48],"or":[49],"use":[50],"vitro":[52],"culture":[53],"systems,":[54],"which":[55,87,113],"do":[56],"not":[57],"reflect":[58],"human":[60,74,99,125,175,214],"vivo":[62,170],"situation,":[63],"potentially":[64],"leading":[65],"results":[67],"cannot":[69],"be":[70,118,220],"fully":[71],"translated":[72],"into":[73],"therapy.":[76],"Therefore,":[77],"it":[78],"necessary":[80],"establish":[82],"a":[83,98,108,124,174,206],"new":[84],"model,":[86,111,142],"allows":[88],"study":[90],"of":[91,97,107,123,146,158,166,190,243,256,263],"context":[96],"system.":[101,127],"We":[102],"focused":[103],"on":[104,273],"establishment":[106],"humanized":[109,140,180],"different":[114],"immunomodulatory":[115,136,167,191],"tested":[119],"presence":[122],"Results":[128],"First":[129],"experiments":[130],"concerning":[131],"suitability":[133],"test":[135,187],"revealed":[143],"effects":[145,154],"checkpoint-control":[147],"antibody":[148],"a-CTLA-4":[149],"were":[150],"similar":[151],"seen":[155],"patients":[157],"clinical":[159,276],"studies.":[160],"To":[161],"analyse":[162],"anti-tumor":[164],"activities":[165],"we":[171],"establishing":[173],"melanoma-like":[176,207],"tumor":[177,212],"mice.":[181],"Conclusions":[182],"This":[183],"enables":[184],"us":[185],"efficacy":[189],"agonistic":[192],"(such":[194,201],"as":[195,202],"CP-870,893)":[196],"checkpoint":[198],"anti-CTLA-4)":[203],"eliminating":[205],"tumor.":[208],"Furthermore,":[209],"parameters":[210],"like":[211],"infiltrating":[213],"cells":[215],"und":[216],"cytokine/chemokine":[217],"production":[218],"analysed.":[221],"References":[222],"Schuster":[223],"M,":[224],"Nechansky":[225],"A,":[226],"Loibner":[227],"H.":[228],"Cancer":[229,240],"immunotherapy.":[230],"Biotechnol":[231],"J":[232],"2006;1:138\u2013147.":[233],"Mellman":[234],"I,":[235],"Coukos":[236],"G,":[237],"Dranoff":[238],"G.":[239],"comes":[242],"age.":[244],"Nature":[245],"rev":[246],"2011;480:480\u2013489.":[247],"Finn":[248],"OJ.":[249],"Immuno-oncology:":[250],"understanding":[251],"function":[253],"dysfunction":[255],"cancer.":[261],"Annals":[262],"Oncology":[264],"2012;23:vii6\u2013vii9.":[265],"Langer":[266],"LF,":[267],"Clay":[268],"TM,":[269],"Morse":[270],"MA.":[271],"Update":[272],"anti-CTLA-4":[274],"trials.":[277],"Expert":[278],"Opin":[279],"Biol":[280],"Ther":[281],"2007;8:1245\u20131256.":[282],"Disclosure":[283],"Information":[284],"C.":[285],"Reitinger:":[286],"None.":[287,290],"F.":[288],"Nimmerjahn:":[289]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-10-11T00:00:00"}